Prosecution Insights
Last updated: August 18, 2026

Examiner: JAVANMARD, SAHAR

Tech Center 1600 • Art Units: 1617 1622 1627

This examiner grants 65% of resolved cases

Performance Statistics

65.3%
Allow Rate
+5.3% vs TC avg
782
Total Applications
+34.8%
Interview Lift
1042
Avg Prosecution Days
Based on 746 resolved cases, 2023–2026

Rejection Statute Breakdown

1.1%
§101 Eligibility
14.5%
§102 Novelty
46.8%
§103 Obviousness
16.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18280396 TRICYCLIC PESTICIDAL COMPOUNDS Non-Final OA BASF SE
18101220 ANTIFUNGAL PROPHYLAXIS FOR CORNEA Non-Final OA PRESIDENT AND FELLOWS OF HARVARD COLLEGE
18468258 NON-HALLUCINOGENIC ARIADNE ANALOGS FOR TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS Non-Final OA The Trustees of Columbia University in the City of New York
18497296 2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS Non-Final OA NOVARTIS AG
18553411 COMPOSITIONS FOR BINDING SPHINGOSINE-1-PHOSPHATE RECEPTOR 1 (S1P1), IMAGING OF S1P1, AND PROCESSES FOR PREPARATION THEREOF Non-Final OA Washington University
18272022 FERROPORTIN-INHIBITORS FOR THE USE IN THE TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS) Non-Final OA Vifor (International) AG

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month